Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists | Semantic Scholar
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors | Circulation
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes | Nature Reviews Nephrology
GLP-1 Agonist Effects on Glucagon Suppression
A new mechanism of action of glucagon‐like peptide‐1 agonist in hepatic steatosis: Promotion of hepatic insulin clearance through induction of carcinoembryonic antigen‐related cell adhesion molecule 1 - Czech - 2018 - Hepatology
Nephroprotective effects of GLP-1 receptor agonists: where do we stand? | SpringerLink
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1 - ScienceDirect
Glucagon-Like Peptide-1 Receptor Agonists in Adult Patients With Type 2 Diabetes: Review of Cardiovascular Outcome Trials - Canadian Journal of Diabetes
A new mechanism of action of glucagon‐like peptide‐1 agonist in hepatic steatosis: Promotion of hepatic insulin clearance through induction of carcinoembryonic antigen‐related cell adhesion molecule 1 - Czech - 2018 - Hepatology
Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes | Diabetes Spectrum
Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension | Arteriosclerosis, Thrombosis, and Vascular Biology
Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force | SpringerLink
Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus
Glucagon-like peptide-1 - Wikipedia
Frontiers | Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD | Endocrinology
IJMS | Free Full-Text | Glucagon, GLP-1 and Thermogenesis | HTML
Mechanism of action of glucagon-like peptide-1 (GLP-1) receptor... | Download Scientific Diagram
Give the Receptor a Brake: Slowing Gastric Emptying by GLP-1 | Diabetes
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1 - ScienceDirect
Time for Glucagon like peptide-1 receptor agonists treatment for patients with NAFLD? - Journal of Hepatology
GLP-1 actions and target organs. GLP-1, through its receptor GLP-1R,... | Download Scientific Diagram
GLP-1 Receptor Agonists in T2D Management: The Modern Injectable (Transcript)
Glucagon-like Peptide (GLP-1) and the treatment of diabetes - YouTube
Glucagon-like peptide 1 (GLP-1) - ScienceDirect
The Cardiovascular Biology of Glucagon-like Peptide-1 - ScienceDirect
